证券日报网讯泰禾股份（301665）11月17日在互动平台回答投资者提问时表示，截至2025年11月10日， 公司股东总户数为12，794户。 ...

格隆汇11月17日丨泰禾股份(301665.SZ)在互动平台表示，公司暂未涉及lifsi产品。 ...

Core Points - On November 12, Taihe Co., Ltd. experienced a decline of 1.65% in stock price, with a trading volume of 91.42 million yuan [1] - The financing data for Taihe on the same day showed a financing purchase amount of 8.13 million yuan and a financing repayment of 8.92 million yuan, resulting in a net financing outflow of 0.79 million yuan [1] - As of November 12, the total margin balance for Taihe was 85.12 million yuan, accounting for 7.20% of its market capitalization [1] Financing and Margin Data - The financing purchase on November 12 was 8.13 million yuan, while the current financing balance stands at 85.12 million yuan [1] - No shares were sold or repaid in the securities lending segment on November 12, with a total of 0 shares and 0 yuan in margin balance [1] Company Overview - Taihe Co., Ltd. is located in Changning District, Shanghai, and was established on April 29, 2004, with its listing date set for April 11, 2025 [1] - The company specializes in the research, production, and sales of pesticide products and functional chemicals, with revenue composition as follows: herbicides 43.14%, fungicides 37.30%, functional chemicals 9.98%, and others 9.57% [1] Financial Performance - For the period from January to September 2025, Taihe reported a revenue of 3.89 billion yuan and a net profit attributable to shareholders of 367 million yuan, reflecting a year-on-year growth of 120.56% [1] Shareholder Information - As of November 10, the number of shareholders for Taihe was 12,800, an increase of 3.62% from the previous period, with an average of 2,989 circulating shares per person, a decrease of 3.49% [1] - Since its A-share listing, Taihe has distributed a total of 270 million yuan in dividends [2] - As of September 30, 2025, Hong Kong Central Clearing Limited was the sixth largest circulating shareholder, holding 230,200 shares, a decrease of 171,700 shares from the previous period [2]

（文章来源：证券日报） 证券日报网讯泰禾股份11月12日在互动平台回答投资者提问时表示，截至2025年11月10日，公司股东总 户数为12794户。 ...

Group 1 - The core product, Baisijia, is a proprietary product developed by the company, indicating a focus on innovation and product differentiation [2] - The gross margin of the new product, Cyproconazole, is expected to exceed the average gross margin of the company's existing products, suggesting potential for improved profitability [2]

Core Insights - The report highlights the IPO activities in Jiangsu province for October 2025, indicating a stable trend with 9 new A-share companies listed, similar to previous months [1][10]. Group 1: IPO Overview - In October 2025, Jiangsu saw the listing of 1 new company, Changjiang Energy Materials, on the Beijing Stock Exchange, with a fundraising amount of 1.84 billion [2][10]. - For the first ten months of 2025, Jiangsu ranked first among provinces with 21 new A-share companies, surpassing Guangdong by 4 companies [10][17]. - The total fundraising amount for Jiangsu's IPOs in the first ten months reached 129.27 billion, placing it third nationally [17][29]. Group 2: City-wise IPO Distribution - Suzhou led the province with 7 new A-share companies in the first ten months, followed by Wuxi and Changzhou with 3 each [10][17]. - The distribution of new A-share companies by city in October 2025 shows that Jiangsu's cities are actively participating in the IPO market, with various cities contributing to the overall count [5][10]. Group 3: Fundraising Analysis - The total fundraising for Jiangsu's IPOs in October was relatively low at 1.84 billion, indicating a need for more robust fundraising activities [17]. - Suzhou's total fundraising amount for the first ten months was 57.48 billion, maintaining its position as the top city in Jiangsu for IPO fundraising [17][13]. Group 4: Sector and Board Distribution - The newly listed companies in Jiangsu for the first ten months were distributed across four boards, with the Growth Enterprise Market (GEM) having the highest number at 7 companies [17][11]. - The breakdown of the newly listed companies by board shows a diverse participation across different sectors, reflecting the province's economic landscape [11][17]. Group 5: IPO Pipeline and Support - As of the end of October, there were 301 companies in the IPO application queue nationwide, with Jiangsu having 51, ranking third in the country [29]. - Jiangsu also leads in the number of companies undergoing IPO guidance, with 243 firms, indicating a strong support system for potential IPO candidates [29][26].

Group 1 - The core viewpoint of the article is that Taihe Co., Ltd. (301665) has clarified its business focus and product offerings in response to investor inquiries [1] - Jiangxi Yangli New Materials Co., Ltd. primarily engages in the research, production, and sales of functional chemicals [1] - The main products of the company include m-phenylenediamine and benzophenone, with downstream applications in material-related sectors [1] - The company does not currently involve itself in robotics or related businesses [1]

Core Viewpoint - The company, Taihe Co., Ltd. (301665), is set to gradually launch its proprietary product, cyhalofop-butyl, globally, with Brazil identified as a key market for expansion. This product is expected to become a new growth driver for the company and facilitate its strategic transition from "generic" to "proprietary," enhancing its global competitiveness [1]. Group 1 - The company will promote the proprietary product cyhalofop-butyl globally [1] - Brazil is a key market for the company's expansion efforts [1] - The product is anticipated to be a new performance growth point for the company [1] Group 2 - The strategic transition from "generic" to "proprietary" is a significant focus for the company [1] - The launch of the new product aims to enhance the company's global competitiveness [1]

Group 1 - The core viewpoint of the article is that Taihe Co., Ltd. (301665.SZ) has clarified its business focus on functional chemicals, specifically mentioning its main products such as m-phenylenediamine and benzophenone [1] - Jiangxi Yangli New Materials Co., Ltd. is primarily engaged in the research, production, and sales of functional chemicals [1] - The downstream products of m-phenylenediamine can be utilized in material applications, indicating the company's involvement in the materials sector [1]

Group 1 - The core viewpoint of the article is that Jiangxi Yangli New Materials Co., Ltd. has been recognized as a specialized and innovative company, and there is an inquiry regarding its specific business and product applications [2] - Jiangxi Yangli New Materials Co., Ltd. primarily engages in the research, development, production, and sales of functional chemicals [2] - The main products of the company include m-phenylenediamine and benzophenone, with downstream applications in material-related sectors [2]